135 related articles for article (PubMed ID: 38154525)
1. Guben Qingfei decoction attenuates LPS-induced acute lung injury by modulating the TLR4/NF-κB and Keap1/Nrf2 signaling pathways.
Zeng Z; Fu Y; Li M; Shi Y; Ding Q; Chen S
J Ethnopharmacol; 2024 Apr; 323():117674. PubMed ID: 38154525
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of
Shi K; Xiao Y; Dong Y; Wang D; Xie Y; Tu J; Xu K; Zhou Z; Cao G; Liu Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555773
[TBL] [Abstract][Full Text] [Related]
3. Bakuchiol regulates TLR4/MyD88/NF-κB and Keap1/Nrf2/HO-1 pathways to protect against LPS-induced acute lung injury in vitro and in vivo.
Zhao L; Zhang Z; Li P; Gao Y; Shi Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3301-3312. PubMed ID: 37930390
[TBL] [Abstract][Full Text] [Related]
4. Ethanol extracts of Rhaponticum uniflorum (L.) DC inflorescence ameliorate LPS-mediated acute lung injury by alleviating inflammatory responses via the Nrf2/HO-1 signaling pathway.
Zhen D; Liu C; Huang T; Fu D; Bai X; Ma Q; Jiang M; Gong G
J Ethnopharmacol; 2022 Oct; 296():115497. PubMed ID: 35738472
[TBL] [Abstract][Full Text] [Related]
5. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
6. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z
Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920
[TBL] [Abstract][Full Text] [Related]
7. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway.
Zhu Y; Han Q; Wang L; Wang B; Chen J; Cai B; Wu C; Zhu X; Liu F; Han D; Dong H; Jia Y; Liu Y
J Ethnopharmacol; 2023 Jan; 301():115763. PubMed ID: 36183949
[TBL] [Abstract][Full Text] [Related]
8. Total terpenoids of Inula japonica activated the Nrf2 receptor to alleviate the inflammation and oxidative stress in LPS-induced acute lung injury.
Zhang J; Zhang M; Zhang WH; Zhu QM; Ning J; Huo XK; Xiao HT; Sun CP
Phytomedicine; 2022 Dec; 107():154377. PubMed ID: 36116200
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
10. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
11. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
12. Hydnocarpin D attenuates lipopolysaccharide-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway.
Hong H; Lou S; Zheng F; Gao H; Wang N; Tian S; Huang G; Zhao H
Phytomedicine; 2022 Jul; 101():154143. PubMed ID: 35537248
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
14. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-κB signaling pathways.
Sun CY; Xu LQ; Zhang ZB; Chen CH; Huang YZ; Su ZQ; Guo HZ; Chen XY; Zhang X; Liu YH; Chen JN; Lai XP; Li YC; Su ZR
Int Immunopharmacol; 2016 Mar; 32():55-61. PubMed ID: 26800098
[TBL] [Abstract][Full Text] [Related]
16. Monochasma savatieri Franch. protects against acute lung injury via α7nAChR-TLR4/NF-κB p65 signaling pathway based on integrated pharmacology analysis.
Zhao M; Yang M; Du J; Cao X; Zhong L; Li W; Chen Y; Peng M; Guo H; Zhou T; Zhang C; Ren Z; Ding Z; Zhong R; Wang Y; Shu Z
J Ethnopharmacol; 2024 Mar; 321():117487. PubMed ID: 38030024
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
18. Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway.
Deng G; He H; Chen Z; OuYang L; Xiao X; Ge J; Xiang B; Jiang S; Cheng S
Biomed Pharmacother; 2017 Dec; 96():148-152. PubMed ID: 28972887
[TBL] [Abstract][Full Text] [Related]
19. Pyrogallol enhances therapeutic effect of human umbilical cord mesenchymal stem cells against LPS-mediated inflammation and lung injury via activation of Nrf2/HO-1 signaling.
Zhang Y; Yang S; Qiu Z; Huang L; Huang L; Liang Y; Liu X; Wang M; Zhou B
Free Radic Biol Med; 2022 Oct; 191():66-81. PubMed ID: 36028178
[TBL] [Abstract][Full Text] [Related]
20. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
